Minerva Neurosciences, Inc.
NERV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $13 | $13 | $17 |
| - Cash | $12 | $15 | $17 | $21 |
| + Debt | $0 | $60 | $60 | $60 |
| Enterprise Value | – | $58 | $56 | $55 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$3 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$3 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.36 | -0.43 | -0.5 | -0.56 |
| % Growth | 16.3% | 14% | 10.7% | – |
| Operating Cash Flow | -$3 | -$2 | – | -$5 |
| Capital Expenditures | -$0 | -$0 | – | $0 |
| Free Cash Flow | -$3 | -$2 | – | -$5 |